Breaking News

Catalent Invests $7.3M at Aprilia, Italy Facility

Expands Softgel Encapsulation and Packaging Capabilities

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Catalent Pharma Solutions has completed the first phase of a $7.3 million investment to upgrade and expand its packaging and softgel encapsulation capabilities at its facility in Aprilia, Italy.   The first phase, completed in August 2018, expanded and upgraded the facility’s integrated packaging capabilities, and commissioned the first of five new softgel encapsulation lines. The second phase to add a further four encapsulation lines, will bring the total number of lines to 23 and significant...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters